The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A randomized, multicenter, open-label phase III trial of hyperthermic intraperitoneal chemotherapy in platinum-resistant recurrent ovarian cancer (KOV-HIPEC-02).
 
Myong Cheol Lim
Consulting or Advisory Role - AstraZeneca; Boryung; CKD Pharm; Genexine; GI Innovation; Hospicare; Takeda
Research Funding - Abbvie (Inst); Amgen (Inst); Astellas Pharma; AstraZeneca (Inst); BeiGene (Inst); Cellid (Inst); CKD pharm (Inst); Clovis Oncology (Inst); Eisai (Inst); Genexine (Inst); GlaxoSmithKline (Inst); Incyte (Inst); Incyte (Inst); Merck (Inst); MSD (Inst); OncoQuest (Inst); Pfizer (Inst); Roche (Inst)
 
Ji Hyun Kim
No Relationships to Disclose
 
Eun Young Park
No Relationships to Disclose
 
Dae Hoon Jeong
No Relationships to Disclose
 
Yoo-Young Lee
No Relationships to Disclose
 
Chel Hun Choi
No Relationships to Disclose
 
Sungjong Lee
No Relationships to Disclose
 
Shin-Wha Lee
No Relationships to Disclose
 
Jeong-Yeol Park
No Relationships to Disclose
 
Se Ik Kim
No Relationships to Disclose
 
Jong Chul Baek
No Relationships to Disclose
 
Hyeong In Ha
No Relationships to Disclose
 
Yong Jung Song
No Relationships to Disclose
 
Seob Jeon
No Relationships to Disclose
 
Taek Sang Lee
No Relationships to Disclose
 
Hye won Jeon
No Relationships to Disclose
 
Ki Hyung Kim
No Relationships to Disclose
 
Sang-Yoon Park
No Relationships to Disclose